Literature DB >> 9708868

Increased capsaicin-induced secondary hyperalgesia as a marker of abnormal sensory activity in patients with fibromyalgia.

V Morris1, S Cruwys, B Kidd.   

Abstract

In this study, capsaicin-induced secondary hyperalgesia was assessed as a marker of abnormal nociceptive processing in patients with fibromyalgia (FM). The area of mechanical secondary hyperalgesia induced by a standard solution of capsaicin placed on the volar forearm was measured in ten patients with FM and the results compared to those obtained in ten patients with rheumatoid arthritis (RA) and ten normal subjects. The area of secondary hyperalgesia was found to be substantially increased in both the FM and RA groups compared with controls. In the FM group the area of hyperalgesia correlated with the overall pain score and with the joint tenderness score. The results suggest that in FM there is enhanced sensitivity of nociceptive neurones at a spinal level, thereby supporting the concept of a generalised disturbance of pain modulation in this disorder.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9708868     DOI: 10.1016/s0304-3940(98)00443-1

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  18 in total

Review 1.  Neuropharmacologic targets and agents in fibromyalgia.

Authors:  Rie Suzuki; Anthony H Dickenson
Journal:  Curr Pain Headache Rep       Date:  2002-08

Review 2.  Botulinum toxin for pain.

Authors:  Roberto Casale; Valeria Tugnoli
Journal:  Drugs R D       Date:  2008

Review 3.  Review of overlap between thermoregulation and pain modulation in fibromyalgia.

Authors:  Alice A Larson; José V Pardo; Jeffrey D Pasley
Journal:  Clin J Pain       Date:  2014-06       Impact factor: 3.442

4.  Nociceptive aspects of fibromyalgia.

Authors:  A A Larson; K J Kovács
Journal:  Curr Pain Headache Rep       Date:  2001-08

5.  Self-reported sleep duration associated with distraction analgesia, hyperemia, and secondary hyperalgesia in the heat-capsaicin nociceptive model.

Authors:  Claudia M Campbell; Sara C Bounds; Mpepera B Simango; Kenneth R Witmer; James N Campbell; Robert R Edwards; Jennifer A Haythornthwaite; Michael T Smith
Journal:  Eur J Pain       Date:  2010-12-30       Impact factor: 3.931

Review 6.  Altered Central Sensitization and Pain Modulation in the CNS in Chronic Joint Pain.

Authors:  Lars Arendt-Nielsen; Søren T Skou; Thomas A Nielsen; Kristian K Petersen
Journal:  Curr Osteoporos Rep       Date:  2015-08       Impact factor: 5.096

Review 7.  Pain in patients with fibromyalgia syndrome.

Authors:  D C Turk; A Okifuji
Journal:  Curr Rheumatol Rep       Date:  2000-04       Impact factor: 4.592

8.  Short-term efficacy of topical capsaicin therapy in severely affected fibromyalgia patients.

Authors:  Benigno Casanueva; Baltasar Rodero; Covadonga Quintial; Javier Llorca; Miguel A González-Gay
Journal:  Rheumatol Int       Date:  2012-07-28       Impact factor: 2.631

Review 9.  [Neuroendocrine changes and maladaptations in fibromyalgia. Etiopathogenetic findings].

Authors:  K Thieme
Journal:  Orthopade       Date:  2004-05       Impact factor: 1.087

10.  individual variation in sleep quality and duration is related to cerebral mu opioid receptor binding potential during tonic laboratory pain in healthy subjects.

Authors:  Claudia M Campbell; Sara C Bounds; Hiroto Kuwabara; Robert R Edwards; James N Campbell; Jennifer A Haythornthwaite; Michael T Smith
Journal:  Pain Med       Date:  2013-09-18       Impact factor: 3.750

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.